The Asia Pacific Neurovascular Devices Market would witness market growth of 9.6% CAGR during the forecast period (2022-2028).
Devices for neuro-thrombectomy are essential for treating ischemic stroke, a prevalent type of stroke in older people. The incidence of stroke among persons older than 40 has been linked to modern lifestyles, stress, and unhealthy dietary habits. In addition, more than half of patients need physical support or assistance after a stroke event, making stroke the main cause of disability among elderly people. Correspondingly, a rise in mechanical thrombectomy treatments and a high acceptance of technologically sophisticated devices promote market growth.
Neurovascular (NV) conditions affecting the central nervous system or the brain are the focus of interventional neurology's diagnosis and treatment. Fluoroscopy, angiography, and endovascular catheters focusing on a certain function are common IN devices. Compared to cardiovascular stents, neurovascular stents need to be significantly more flexible & elastic and require much finer design and fabrication. Stents made of shape memory polymer (SMP) are more effective for neurovascular operations.
China's population is aging at one of the world's quickest rates. By 2040, there will be 28% of individuals in China who are over 60 as a result of rising life expectancy and falling fertility rates. In particular, creating an integrated system that meets the health & social needs of elderly people while ensuring everybody has access to healthcare, regardless of location, is one of the many new opportunities and challenges this profound demographic shift presents for public health & socioeconomic development. The region's aging population will increase the need for neurovascular devices because the elderly are more vulnerable to neurovascular diseases.
The China market dominated the Asia Pacific Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $316.9 million by 2028. The Japan market is estimated to grow a CAGR of 8.9% during (2022 - 2028). Additionally, The India market would experience a CAGR of 10.3% during (2022 - 2028).
Based on End User, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Neurovascular Devices Market is Projected to reach USD 4.2 Billion by 2028, at a CAGR of 8.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
By End User
By Technology
By Disease Pathology
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
